CD8A and colorectal carcinoma: However, the overexpression of GSDME combined with αPD1 showed its treatment efficacy of CT26 tumors with the gradual increase of their number and abilities of CD8+T cells, which suggested that GSDME benefits the effect of αPD1 through CD8+T cells mediated anti-immunity of MSS CRC animal model.